首页>
外国专利>
BISPECIFIC FUSION PROTEIN AND METHOD OF USE FOR ENHANCING EFFECTOR CELL KILLING OF TARGET CELLS
BISPECIFIC FUSION PROTEIN AND METHOD OF USE FOR ENHANCING EFFECTOR CELL KILLING OF TARGET CELLS
展开▼
机译:双特异性融合蛋白及其用于增强靶细胞效应细胞杀伤的方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides a nucleic acid encoding IFN- alpha fusion proteins. The specification also describes the proteins encoded by said nucleic acids, methods of making IFN- alpha fusion proteins and methods of utilizing the compounds for the treatment of cancer. One specific IFN- alpha fusion protein comprising IFN- alpha or a portion thereof capable of enhancing the killing ability of an effector cell and an anti-CD20 antibody, such as RITUXAN, which can target, for example, B cell lymphomas ie.g./i, non-Hodgkin's lymphoma).
展开▼